FindTrial
Sign In

Clinical analysis of the sedative effect of dexmedetomidine nasal drops combined with sevoflurane in children's MRI

Clinical analysis of the sedative effect of dexmedetomidine nasal drops combined with sevoflurane in children's MRI

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000031961
Enrollment
Unknown
Registered
2020-04-16
Start date
2020-04-15
Completion date
Unknown
Last updated
2020-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pediatric sedation

Interventions

Group A:intranasal dexmedetomidine combination with inhalation sevoflurane
Group B:Intranasal dexmedetomidine combination with oral chloral hydrate
Group C:intranasal dexmedetomidine and ketamine
Group D:inhalation sevoflurane
Group E:Intranasal dexmedetomidine combination with buccal midazolam
Group F:Intravenous dexmedetomidine and propofol
Group G:Intravenous dexmedetomidine and midazolam
Group H:intravenous propofol
Group I:intravenous dexmedetomidine

Sponsors

Children's Hospital Affiliated to Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients younger than 18 years old; 2. ASA class I-III.

Exclusion criteria

Exclusion criteria: 1. Patients with serious hepatorenal diseases; 2. Patients with contraindications to the drugs used

Design outcomes

Primary

MeasureTime frame
the success rate of sedation;heart rate;blood pressure;oxygen saturation;time;adverse reactions;degree of satisfaction;—

Countries

China

Contacts

Public ContactTang Wen

Children's Hospital Affiliated to Chongqing Medical University

tangwen1110@163.com+86 18883909278

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026